
    
      This is a double-blind, placebo controlled, crossover design study of the safety of
      ferumoxytol compared to placebo. Patients are randomized to receive either one 510 mg dose of
      ferumoxytol or the equivalent volume of normal saline followed by the other test article
      given one week later.
    
  